2013
DOI: 10.4269/ajtmh.13-0157
|View full text |Cite
|
Sign up to set email alerts
|

Dogma in Classifying Dengue Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
20
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 30 publications
0
20
0
2
Order By: Relevance
“…[9][10][11] This issue confounds the ability to compare our results with those that used different case classifications or that were conducted in a pediatric setting. [12][13][14][15][16] Our study in adolescents and adults showed that, in this series, specific clinical aspects existed for each serotype.…”
Section: Discussionmentioning
confidence: 95%
“…[9][10][11] This issue confounds the ability to compare our results with those that used different case classifications or that were conducted in a pediatric setting. [12][13][14][15][16] Our study in adolescents and adults showed that, in this series, specific clinical aspects existed for each serotype.…”
Section: Discussionmentioning
confidence: 95%
“…The studies in refs. 26 and 29 argue—mainly with reference to the study by Alexander and others4 and the study in ref. 10—that D/SD offers a better categorization than the DF/DHF/DSS classification.…”
Section: Discussionmentioning
confidence: 96%
“…29). In this section, we will consider these three main areas of application of the dengue case classification.…”
Section: Discussionmentioning
confidence: 99%
“…In a disease like dengue with a broad clinical spectrum, research to elucidate mechanistic pathways underlying specific phenomena relies on careful characterisation of individual clinical phenotypes. The extent to which the original WHO 1997 and the revised 2009 dengue classification systems facilitate pathophysiology research has been a matter of some debate [29,30]. For example, it has been argued that the 2009 severe dengue entity represents a mix of end-stage manifestations involving various clinical pathways and potentially including comorbidities and/or iatrogenic factors [31].…”
Section: Discussionmentioning
confidence: 99%